Accretion Pharmaceuticals Limited has informed the Exchange about General Updates
EarningsCanvas
Loading your research…
Opening the latest published company and exchange records.
EarningsCanvas
Opening the latest published company and exchange records.
NSE · NSE SME · BSE
Results, orders and company updates, with a trail back to the filing. Check the feed status below for freshness.
Exchange intelligence
An exchange could not be refreshed. These are last known disclosures. Check the official exchange for newer announcements.
Accretion Pharmaceuticals Limited has informed the Exchange about General Updates
Accretion Pharmaceuticals Limited has informed the Exchange about Investor Presentation
Accretion Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Accretion Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 31, 2026, titled "Company Reports 25.83% Revenue Growth and 72.63% PAT Growth in H1 FY27 and Strong EBITDA Growth of 72.28%; EBITDA Margin Improves to 22.48%".
Accretion Pharmaceuticals Limited has submitted to the Exchange, the unaudited financial results for the half year ended September 30, 2026.